Oaktree Acquisition Corp. III Life Sciences (OACC) Other Operating Expenses (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACC) reported Other Operating Expenses of $456538.0 for Q1 2026, up 2.64% on a YoY basis from $444802.0 in Q1 2025, and up 78.69% quarter-over-quarter from $255496.0 in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) Other Operating Expenses (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Other Operating Expenses for 2 years, with the latest figure at $456538.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Operating Expenses rose 2.64% year-over-year to $456538.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (changed N/A YoY), and the FY2025 full-year result was $1.2 million, up 239.87% from the prior year.
  • Other Operating Expenses for Q1 2026 stood at $456538.0, up from $255496.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $456538.0 in Q1 2026, with the low at $225579.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn -
2 Berto Acquisition 312.46 Mn 312.46 Mn -
3 Centurion Acquisition 311.65 Mn 311.65 Mn -
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn -
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn -
6 WEN Acquisition 309.15 Mn 309.15 Mn -
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn -
8 Soulpower Acquisition 264.91 Mn 264.91 Mn -
9 BTC Development 262.16 Mn 262.16 Mn -
10 Oaktree Acquisition Corp. III Life Sciences 57.34 Mn 57.34 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 456,538.00
Dec 31, 2025 255,496.00
Sep 30, 2025 225,579.00
Jun 30, 2025 269,810.00
Mar 31, 2025 444,802.00